Nutrition support to patients undergoing gastrointestinal surgery

Protein-energy malnutrition is a common problem in hospital patients. Studies have reported 40% of surgical and medical patients to be malnourished on admission to hospital. The majority of patients experienced nutritional depletion during the course of their hospital admission, which was more severe in those patients who were already depleted at the time of their admission [1]. The consequences of pre-operative malnutrition were first recognised in the 1930's. Studley observed a direct relationship between preoperative weight loss and operative mortality rate, independent of factors such as age, impaired cardiorespiratory function and type of surgery [2]. The importance of nutritional depletion as a major determinant of the development of postoperative complications has subsequently been confirmed by Giner et al [3]. The absence of a standardised definition of nutritional depletion has led to surrogate markers of nutritional status being utilised. Albumin, muscle function tests, immunological status and weight loss are used as these show correlation with postoperative morbidity and mortality.

Nutritional depletion is associated with changes in body composition, tissue wasting and impaired organ function which leads to impaired immune and muscle function. Thus, depleted patients are at risk from infectious complications and cardiorespiratory impairment [4, 5]. Patients who undergo gastrointestinal surgery are at risk of nutritional depletion from inadequate nutritional intake; both preoperatively and postoperatively, the stress of surgery and the subsequent increase in metabolic rate.

More recently, ensuring adequate nutritional intake has been a major focus of perioperative care and research has focused on the methods of delivering nutritional support, their comparative clinical benefits and minimising the metabolic changes associated with surgical trauma.

The physiological stress of surgical trauma causes a surge of sympathetic activity and an associated rise in catecholamine secretion. These changes are transient. A more prolonged hypermetabolic state associated with a pronounced negative nitrogen balance then follows. Metabolic rate is typically increased by about 10% postoperatively [6]. If adequate nutritional support is not provided at this stage then excessive skeletal muscle proteolysis occurs with further depression of metabolism. Increased energy expenditure is associated with a range of hormonal responses that occur as a result of surgical trauma. Cytokines, including Tumour Necrosis Factor (TNF) and interleukins (IL-1 and IL-6) have an important role in determining longer-term metabolic changes [7]. These changes may not be clinically relevant unless postoperative sepsis or trauma follows surgery but in conjunction with preoperative starvation often results in a significant negative nitrogen balance.

It has been proved that intestinal permeability is increased two to fourfold in the immediate postoperative period, although this normalises within five days [8]. In addition, nutritional depletion is associated with increased intestinal permeability and a decrease in villous height [9]. These findings have lead to the investigation of treatments aimed at maintaining an intact mucosal barrier. Increased intestinal permeability indicates a failure of the gut barrier function to exclude endogenous bacteria and toxins. These have been proposed as causative agents in the systemic inflammatory response syndrome, sepsis and multi-organ failure. However, there has been a failure thus far to prove a correlation between failure of gut barrier function and septic complications after major upper gastrointestinal failure [10].

Nutritional support leads to improved nutritional status and clinical outcome in severely depleted patients [11]. Studies of postoperative nutritional support have demonstrated reduced morbidity and reduced length of hospital stay [12]. There is also evidence that artificial nutritional support in malnourished patients is cost effective by reducing the costs associated with length of stay and morbidity and improved quality of life [13]. It is important, however, to consider the most clinically appropriate and beneficial means of delivering nutritional support to surgical patients.

Conventional treatment after bowel resection has typically entailed starvation with administration of intravenous fluids until passage of flatus, principally due to concerns over post-operative ileus. This was based on the assumption that oral feeding may not be tolerated in the presence of ileus and the integrity of the newly constructed anastomosis may be compromised. However, small intestinal motility recovers 6–8 hours after surgical trauma and moderate absorptive capacity exists even in the absence of normal peristalsis [14]. It has since been shown that postoperative enteral feeding in patients undergoing gastrointestinal resection is safe and well tolerated even when started within 12 hours of surgery [15, 16]. The commonest observed adverse effects were gastrointestinal, such as abdominal cramps and bloating [16].

An appropriate delivery method should be selected, depending on the anticipated duration of enteral feeding, aspiration risk and gastrointestinal anatomy. No specific clinical or nutritional advantages have been shown for jejunostomy feeding and this route should be reserved for patients in whom naso-gastric or naso-jejunal feeding is not feasible or safe [17].

Enteral feeding has been shown to result in some specific clinical benefits, including reducing the incidence of post-operative infectious complications [11] and an improved wound healing response [18]. Enteral nutrition may have other beneficial effects including altering antigen exposure and influencing oxygenation of the gut mucosa. More research is required in this area to elucidate whether enteral nutrition truly modulates gut function or whether tolerance of enteral nutrition is predominantly indicative of a patient with healthy organ function [19].

A large multi-centre clinical trial has shown no significant reduction in morbidity or mortality when Total Parenteral Nutrition (TPN) was administered perioperatively to a heterogeneous group of surgical patients. Stratification of patients in this trial according to nutritional status showed that patients with mild malnutrition did not benefit from TPN but had more infectious complications. This led the authors to conclude that perioperative TPN should be limited to severely malnourished patients in the absence of other specific indications [20]. Subsequent studies have principally focussed on severely malnourished patients with gastrointestinal malignancy. These patients have been shown to experience clinically significant reductions in both infectious and non-infectious complications when fed parenterally for a minimum of ten days pre-operatively [21]. A recent meta-analysis of 27 randomised controlled trials concluded that TPN has no statistically significant effects overall on mortality or morbidity in surgical patients. The most recent studies analysed were of better methodological quality and showed fewer benefits than earlier studies. Studies which included only malnourished patients demonstrated a trend to a reduction in complication rates [22].

Each route of delivery of nutritional support is associated with different complications. Generally, the complications associated with parenteral nutrition are associated with greater morbidity than those associated with enteral nutrition due to the invasive nature of administration. The route of administration also has effects on organ function, particularly the intestinal tract. Substrates delivered by the enteral route are better utilised by the gut than those administered parenterally. In addition, enteral feeding when compared with TPN solutions may prevent gastrointestinal mucosal atrophy, attenuate the trauma stress response, maintain immunocompetence and preserve normal gut flora [23].

A meta-analysis comparing the nutritional efficacy of early enteral and parenteral nutrition in high-risk surgical patients found that early postoperative enteral nutrition was effective and associated with reduced septic morbidity rates compared with those administered TPN even when catheter sepsis was excluded from the analysis [23]. Enteral nutrition is also an effective option in severely malnourished patients with gastrointestinal cancer and is associated with fewer complications, a shorter post-operative hospital stay [25] and reduced costs compared with TPN [26]. The principal conclusions from these studies was that the enteral route should be used whenever possible, but if the enteral route will not be available for more than one week early administration of TPN should be considered.

Evidence to support preoperative nutrition support is limited but suggests that if malnourished individuals are adequately fed for at least 7–10 days preoperatively then surgical outcome can be improved [20]. The obvious disadvantage of this is the increased length of hospital stay resulting from admission for nutritional support and the delay in surgical intervention. There is also some evidence to support preoperative nutrition support in patients with inflammatory bowel disease [27]. Studies have also been carried out which cast doubt on the benefits of the standard preoperative fast and have shown reductions in the postoperative catabolic response and improved well-being [28]. As discussed earlier, there is substantially more evidence to support early post-operative nutritional intervention by an appropriate route.

In addition to ongoing research ascertaining the specific benefits of the routes of delivery for nutrition support, more recent research has also focussed on the composition of nutritional regimens. In particular, much attention has been paid to the potential for specific nutrients to influence the metabolic response to disease.

Glutamine is the most abundant free amino acid in the extra and intracellular compartments. It plays a vital role in nitrogen transport and acid base homeostasis and is a fuel for rapidly dividing cells such as enterocytes, lymphocytes and fibroblasts. It is also involved in antioxidant defence mechanisms by influencing glutathione synthesis. In situations of severe stress or nutritional depletion the demand for glutamine may exceed the body's capacity to synthesise it. Studies have explored the benefits of glutamine-enriched parenteral nutrition regimens, particularly on the gut and immune system. It has been demonstrated that the addition of glutamine to parenteral nutrition regimens given to patients after elective abdominal surgery results in a reduced length of hospital stay [29] and reduced costs [30]. This was accompanied by an improved nitrogen balance and quicker lymphocyte recovery [29]. Glutamine has also been shown to maintain intestinal permeability in postoperative patients [31].

Studies regarding the role of two other potential immunonutrients, arginine and n-3 fatty acids, in gastrointestinal surgery patients have not yet been published.

Randomised controlled trials provide evidence to support the use of enteral feeding in surgical patients and indicate no increased morbidity or mortality. However, no meta-analyses have been carried out to pool the data from a plethora of mainly small trials. To date, these show no reductions in mortality have been shown from enterally fed surgical patients. Some useful meta-analyses have been published for parenterally feeding surgical patients, although many studies were small and of flawed methodological quality as they did not take into account the many surgical and anaesthetic variables that can influence post-operative outcomes. Comparative studies show that, compared with parenteral nutrition, enteral nutrition is well tolerated and is associated with reduced septic morbidity, costs and length of stay. These studies form the basis of the current practice of the enteral feeding route being used wherever possible. Further research is needed to elucidate whether, alongside improvements in surgical technique and perioperative care, enteral nutrition will be associated with overall reductions in morbidity and mortality.

Further research is required to clearly identify which surgical patients will significantly benefit from specific nutritional intervention. This is problematic as assessment of nutritional status is not straightforward and there is also an absence of a standardised definition of nutritional depletion. A standardised, validated definition of nutritional depletion would enable nutrition support to be targeted to those surgical patients most likely to derive significant clinical benefit in terms of improved postoperative outcome. This would also facilitate direct comparison of trial data for large meta-analyses involving "malnourished" patients to provide robust, evidence based guidelines for nutritional support of surgical patients.